We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+5.71%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$330M
AUM Growth
+$19M
Cap. Flow
+$2.32M
Cap. Flow %
0.7%
Top 10 Hldgs %
27.55%
Holding
108
New
3
Increased
30
Reduced
33
Closed
–

Top Buys

Rank Stock Value
1
LMT icon
Lockheed Martin
LMT
+$3.44M
2
TMO icon
Thermo Fisher Scientific
TMO
+$770K
3
NEE icon
NextEra Energy
NEE
+$526K
4
AMZN icon
Amazon
AMZN
+$352K
5
DIS icon
Walt Disney
DIS
+$272K

Top Sells

Rank Stock Value
1
MMM icon
3M
MMM
+$2.9M
2
ACN icon
Accenture
ACN
+$464K
3
IVV icon
iShares Core S&P 500 ETF
IVV
+$229K
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$227K
5
TSCO icon
Tractor Supply
TSCO
+$190K

Sector Composition

Rank Sector Weight
1 Technology 14.19%
2 Healthcare 13.66%
3 Industrials 12.3%
4 Consumer Staples 10.62%
5 Communication Services 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BBH icon
51
VanEck Biotech ETF
BBH
$400M
$2.68M 0.81%
13,295
-380
-3% -$70.7K
USB icon
52
US Bancorp
USB
$98.2B
$2.64M 0.8%
46,401
-365
-0.8% -$21.4K
VB icon
53
Vanguard Morningstar Small-Cap ETF
VB
$79.5B
$2.64M 0.8%
11,712
-515
-4% -$114K
IJH icon
54
iShares Core S&P Mid-Cap ETF
IJH
$122B
$2.48M 0.75%
46,230
+550
+1% +$29.7K
IBB icon
55
iShares Biotechnology ETF
IBB
$9.34B
$2.16M 0.66%
13,221
+290
+2% +$44.7K
CTAS icon
56
Cintas
CTAS
$81.9B
$2.11M 0.64%
22,120
– –
HYG icon
57
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$2.02M 0.61%
22,928
-199
-0.9% -$17.4K
COP icon
58
ConocoPhillips
COP
$147B
$2.01M 0.61%
33,074
-331
-1% -$18.4K
HYD icon
59
VanEck High Yield Muni ETF
HYD
$4.43B
$1.95M 0.59%
30,640
-340
-1% -$21.4K
IAU icon
60
iShares Gold Trust
IAU
$62.9B
$1.81M 0.55%
53,838
-1,001
-2% -$34.6K
GOOG icon
61
Alphabet (Google) Class C
GOOG
$4.36T
$1.79M 0.54%
14,280
– –
JNJ icon
62
Johnson & Johnson
JNJ
$618B
$1.58M 0.48%
9,573
– –
VEU icon
63
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
$1.35M 0.41%
21,239
– –
SYK icon
64
Stryker
SYK
$125B
$1.13M 0.34%
4,354
– –
MMM icon
65
3M
MMM
$90.9B
$1.07M 0.32%
6,452
-17,350
-73% -$2.9M
LLY icon
66
Eli Lilly
LLY
$1.02T
$1.03M 0.31%
4,473
– –
T icon
67
AT&T
T
$159B
$960K 0.29%
44,202
– –
PFE icon
68
Pfizer
PFE
$143B
$955K 0.29%
24,402
– –
CVX icon
69
Chevron
CVX
$392B
$938K 0.28%
8,963
– –
PAYX icon
70
Paychex
PAYX
$41.6B
$832K 0.25%
7,755
– –
ORCL icon
71
Oracle
ORCL
$374B
$794K 0.24%
10,211
-380
-4% -$29.7K
CAT icon
72
Caterpillar
CAT
$375B
$770K 0.23%
3,542
– –
IBM icon
73
IBM
IBM
$211B
$700K 0.21%
5,001
-256
-5% -$35K
SYY icon
74
Sysco
SYY
$40.8B
$636K 0.19%
8,190
– –
PPG icon
75
PPG Industries
PPG
$24.6B
$628K 0.19%
3,700
– –
1 2
3
4 5

Similar funds

SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
TFP
Triune Financial Partners Overland Park, Kansas $421M AUM 22.09% 1-Year Est. Return
MG
MilWealth Group Milwaukee, Wisconsin $420M AUM 12.37% 1-Year Est. Return
HWMG
Hurlow Wealth Management Group Bloomington, Indiana $420M AUM 16.85% 1-Year Est. Return
AI
ArchPoint Investors Coral Gables, Florida $420M AUM 42.19% 1-Year Est. Return
IMA
Investment Management Associates Greenwood Village, Colorado $420M AUM 11.81% 1-Year Est. Return
CMHI
CVC Management Holdings II St. Helier, Jersey $420M AUM 0.05% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return

Boston Research & Management's Q2 2021 Portfolio in Review

As of Q2 2021, Boston Research & Management held 108 positions worth $330M, up 6.1% from $311M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Trading was light in Q2 2021: portfolio turnover was 2.8%. Boston Research & Management opened 3 new positions and made no exits, leaving the 108-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Industrials.

  • Boston Research & Management's largest Q2 2021 buy was Lockheed Martin: 8,945 shares worth $3.38M.
  • Boston Research & Management added most to Thermo Fisher Scientific in Q2 2021, an estimated $770K increase.
  • Boston Research & Management's biggest Q2 2021 reduction was 3M, cutting an estimated $2.9M.
  • Boston Research & Management's ten largest holdings make up 28% of its $330M portfolio in Q2 2021.
  • Boston Research & Management opened 3 new positions and closed 0 in Q2 2021.
  • Boston Research & Management's portfolio value rose 6.1% quarter-over-quarter to $330M.

Based on Boston Research & Management's 13F filing for Q2 2021, filed 11 Aug 2021.